A citation-based method for searching scientific literature

Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
Times Cited: 96







List of co-cited articles
902 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
L Sarantaus, P Vahteristo, E Bloom, A Tamminen, L Unkila-Kallio, R Butzow, H Nevanlinna. Eur J Hum Genet 2001
43
2

Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers.
Helga Primas, Regina Kroiss, Karin Kalteis, Christine Rappaport, Daniela Muhr, Christian Primas, Ernst Kubista, Reinhard Horvat, Peter Oefner, Christian Singer,[...]. Eur J Cancer Prev 2012
4
25


Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes.
Claire Thompson, Ciara McCormick, Waseem Kamran, Ciaran O'Riain, Lucy Norris, David Gallagher, Noreen Gleeson. Ir J Med Sci 2018
5
20


BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett Larson, Jeffrey N Weitzel, Steven A Narod. Gynecol Oncol 2012
45
2

Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
David A Barrington, Macie L Champion, Teresa K L Boitano, Christen L Walters-Haygood, Meagan B Farmer, Ronald D Alvarez, Jacob M Estes, Charles A Leath. Gynecol Oncol 2018
4
25

Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection.
J N McAlpine, S El Hallani, S F Lam, S E Kalloger, M Luk, D G Huntsman, C MacAulay, C B Gilks, D M Miller, P M Lane. Gynecol Oncol 2011
35
2

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.
Ikuko Sakamoto, Yosuke Hirotsu, Hiroshi Nakagomi, Hidetaka Ouchi, Atsushi Ikegami, Katsuhiro Teramoto, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata. Cancer 2016
39
2


Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
P I Stanciu, T E J Ind, D P J Barton, J B Butler, K M Vroobel, A D Attygalle, M A E Nobbenhuis. J Ovarian Res 2019
5
20

Clinical and Pathological Characteristics of Incidental Diagnostic Early Occult Malignancy After Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers.
Ofer Lavie, Michael G Moskoviz, Ron Auslender, Ofer Gemer, Arie Bitterman, Grace Younes, Yakir Segev. Int J Gynecol Cancer 2016
6
16

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.
Myong Cheol Lim, Sokbom Kang, Sang-Soo Seo, Sun-Young Kong, Bo-Yon Lee, Seon-Kyung Lee, Sang-Yoon Park. J Cancer Res Clin Oncol 2009
42
2

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.
P N Tonin, A M Mes-Masson, S A Narod, P Ghadirian, D Provencher. Clin Genet 1999
43
2

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
244
1

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016
1

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
James R Conner, Emily Meserve, Ellen Pizer, Judy Garber, Michael Roh, Nicole Urban, Charles Drescher, Bradley J Quade, Michael Muto, Brooke E Howitt,[...]. Gynecol Oncol 2014
55
1

Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Valentina Chiappa, Maria Luisa Carcangiu, Biagio Paolini, Jvan Casarin, Cono Scaffa, Massimiliano Gennaro, Fabio Martinelli,[...]. J Minim Invasive Gynecol 2017
10
10

Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.
Dirk Müller, Marion Danner, Kerstin Rhiem, Björn Stollenwerk, Christoph Engel, Linda Rasche, Lisa Borsi, Rita Schmutzler, Stephanie Stock. Eur J Health Econ 2018
20
5


Outcomes and Cost Analysis in High-Risk Patients Undergoing Simultaneous Free Flap Breast Reconstruction and Gynecologic Procedures.
Gabriel A Del Corral, Ari M Wes, John P Fischer, Joseph M Serletti, Liza C Wu. Ann Plast Surg 2015
19
5

Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
Angie Tong, Scott Kelly, Rachel Nusbaum, Kristi Graves, Beth N Peshkin, Heiddis B Valdimarsdottir, Marie Wood, Wendy McKinnon, Judy Garber, Shelley R McCormick,[...]. Psychooncology 2015
21
4

Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women.
Martha Hickey, Ines Rio, Alison Trainer, Jennifer L Marino, C David Wrede, Michelle Peate. Menopause 2020
8
12

Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
Jennifer Long, Thomas G Evans, Damian Bailey, Michael H Lewis, Kate Gower-Thomas, Alexandra Murray. Breast J 2018
6
16

A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.
F Lalloo, A Baildam, A Brain, P Hopwood, D G Evans, A Howell. Eur J Surg Oncol 2000
23
4

Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction.
Neda Stjepanovic, Guillermo Villacampa, Kevin T Nead, Sara Torres-Esquius, Guadalupe G Melis, Katherine L Nathanson, Alexandre Teule, Joan Brunet, Teresa R Y Cajal, Gemma Llort,[...]. Eur J Cancer 2020
8
12

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, Abigail S Thomas, Jodie A Cogswell, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2017
34
2


Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Maria Luisa Gasparri, Katayoun Taghavi, Enrico Fiacco, Veronica Zuber, Rosa Di Micco, Guglielmo Gazzetta, Alice Valentini, Michael D Mueller, Andrea Papadia, Oreste D Gentilini. Medicina (Kaunas) 2019
4
25

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo. Cochrane Database Syst Rev 2018
30
3

Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
Sushmita Gordhandas, Barbara M Norquist, Kathryn P Pennington, Rachel L Yung, Mary B Laya, Elizabeth M Swisher. Gynecol Oncol 2019
34
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.